Skip to main content

Advertisement

Log in

Pellagra encephalopathy as a differential diagnosis for Creutzfeldt-Jakob disease

  • Short Communication
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

In the present study we evaluated cases referred as suspected Creutzfeldt-Jakob disease (CJD). Five out of 59 without prion disease showed neuropathological features of pellagra encephalopathy with widespread chromatolytic neurons (age range 40–48 years at death; one woman). These patients presented with a progressive neuropsychiatric disorder lasting for 2 to 24 months. Common symptoms included gait disorder, para- or tetraspasticity, extrapyramidal symptoms, incontinence, and myoclonus. Protein 14-3-3 in the cerebrospinal fluid was examined in a single patient and was positive, allowing the clinical classification as probable sporadic CJD. Pellagra encephalopathy may be considered as a differential diagnosis of CJD including detection of protein 14-3-3.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  • Brown TM (2010) Pellagra: an old enemy of timeless importance. Psychosomatics 51:93–97

    PubMed  Google Scholar 

  • Chitravas N, Jung RS, Kofskey DM, Blevins JE, Gambetti P, Leigh RJ, Cohen ML (2011) Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol 70:437–444

    Article  PubMed  Google Scholar 

  • Gelpi E, Heinzl H, Hoftberger R, Unterberger U, Strobel T, Voigtlander T, Drobna E, Jarius C, Lang S, Waldhor T, Bernheimer H, Budka H (2008) Creutzfeldt-Jakob disease in Austria: an autopsy-controlled study. Neuroepidemiology 30:215–221

    Article  PubMed  Google Scholar 

  • Hauw JJ, De Baecque C, Hausser-Hauw C, Serdaru M (1988) Chromatolysis in alcoholic encephalopathies. Pellagra-like changes in 22 cases. Brain 111(Pt 4):843–857

    Article  PubMed  Google Scholar 

  • Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I (2007) Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 130:1350–1359

    Article  PubMed  CAS  Google Scholar 

  • Ishii N, Nishihara Y (1981) Pellagra among chronic alcoholics: clinical and pathological study of 20 necropsy cases. J Neurol Neurosurg Psychiatry 44:209–215

    Article  PubMed  CAS  Google Scholar 

  • Ishii N, Nishihara Y (1985) Pellagra encephalopathy among tuberculous patients: its relation to isoniazid therapy. J Neurol Neurosurg Psychiatry 48:628–634

    Article  PubMed  CAS  Google Scholar 

  • Josephs KA, Ahlskog JE, Parisi JE, Boeve BF, Crum BA, Giannini C, Petersen RC (2009) Rapidly progressive neurodegenerative dementias. Arch Neurol 66:201–207

    Article  PubMed  Google Scholar 

  • Kovacs GG, Budka H (2009) Molecular pathology of human prion diseases. Int J Mol Sci 10:976–999

    Article  PubMed  CAS  Google Scholar 

  • Kovacs GG, Budka H (2010) Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases. Clin Neuropathol 29:271–288

    PubMed  CAS  Google Scholar 

  • Pfefferbaum A, Adalsteinsson E, Sullivan EV (2006) Dysmorphology and microstructural degradation of the corpus callosum: Interaction of age and alcoholism. Neurobiol Aging 27:994–1009

    Article  PubMed  CAS  Google Scholar 

  • Quadrio I, Perret-Liaudet A, Kovacs GG (2011) Molecular diagnosis of human prion disease. Exp Op Med Diag 5:291–306

    Article  CAS  Google Scholar 

  • Serdaru M, Hausser-Hauw C, Laplane D, Buge A, Castaigne P, Goulon M, Lhermitte F, Hauw JJ (1988) The clinical spectrum of alcoholic pellagra encephalopathy. A retrospective analysis of 22 cases studied pathologically. Brain 111(Pt 4):829–842

    Article  PubMed  Google Scholar 

  • Van Everbroeck B, Dobbeleir I, De Waele M, De Deyn P, Martin JJ, Cras P (2004) Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. J Neurol 251:298–304

    Article  PubMed  Google Scholar 

  • Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659–2668

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was performed in the frame of the Hungarian CJD Surveillance and supported partly by the Project TÁMOP-4-2-1/B-03/1/KMR-2010-001. Assistance of Marianna Lenkeine and Katalin Ress is also acknowledged. We are grateful for the collegues for referring the cases and for the relatives of the patients.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabor G. Kovacs.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kapas, I., Majtenyi, K., Törö, K. et al. Pellagra encephalopathy as a differential diagnosis for Creutzfeldt-Jakob disease. Metab Brain Dis 27, 231–235 (2012). https://doi.org/10.1007/s11011-012-9308-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-012-9308-8

Keywords

Navigation